Indication

Chronic hepatitis D

Chronic hepatitis D is a persistent, progressive hepatic infection caused by the hepatitis D virus, a defective satellite RNA virus that obligately requires the presence of hepatitis B virus surface antigens for replication and propagation. Read more about Chronic hepatitis D

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Chronic hepatitis D therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Chronic hepatitis D preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chronic hepatitis D.

Chronic hepatitis D is a persistent, progressive hepatic infection caused by the hepatitis D virus, a defective satellite RNA virus that obligately requires the presence of hepatitis B virus surface antigens for replication and propagation.

The disease exclusively affects individuals with concomitant hepatitis B virus infection, most frequently arising from a superinfection in chronic hepatitis B carriers.

Pathophysiologically, it is recognized as the most severe form of chronic viral hepatitis, characterized by ongoing viral replication (detectable hepatitis D virus RNA), elevated aminotransferases, necroinflammation, and rapid acceleration of hepatic fibrosis.

Compared to hepatitis B monoinfection, patients with chronic hepatitis D experience a substantially higher and faster risk of developing liver cirrhosis, hepatic decompensation, and hepatocellular carcinoma.

Personalize your experience

Follow Chronic hepatitis D and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it